Leukemias and Lymphomas Associated with the Use of Cytotoxic and Immunosuppressive Drugs
The hematologist is intimately connected with the care of patients undergoing treatment with immunosuppressive or cancer chemotherapeutic agents, many of which have profound effects upon the bone marrow, lymphoid tissues, and the circulating blood. Most changes, such as leukopenia, thrombocytopenia, or anemia are usually reversible when treatment is stopped. However, sometimes progressive myeloproliferative or lymphoproliferative disorders may occur. In this report we shall be concerned mainly with the development of lymphomas in organ transplant recipients and leukemias in patients treated with cancer chemotherapy.
KeywordsMultiple Myeloma Chronic Lymphocytic Leukemia Acute Leukemia Organ Transplant Recipient Acute Myeloblastic Leukemia
Unable to display preview. Download preview PDF.
- 3.Lerner, H.: Second malignancies diagnosed in breast cancer patients while receiving adjuvant chemotherapy at the Pennsylvania Hospital. Proc. Am. Assoc. Cancer Res. 18, 340 (1977)Google Scholar
- 5.Penn, I.: Malignant tumors in organ transplant recipients. Berlin, Heidelberg, New York: Springer 1970Google Scholar
- 9.Penn, I.: Tumors arising in organ transplant recipients. In: Advances in cancer research. Klein, G., Weinhouse, S. (eds.), Vol.28, pp. 31–61. New York: Academic Press 1978Google Scholar
- 10.Penn, I.: Kaposi’s sarcoma in organ transplant recipients. Report of 20 cases. Transplantation (in press)Google Scholar